Please join us for the Life Science & Healthcare Fireside Founder Chat with Fereydoun Firouz, former CEO & President of EMD Serono. Fereydoun and I will be discussing how to build and lead winning teams and creating cultures of excellence in life science companies. We will also discuss the traits of strong leaders and how to a become an effective leader of a complex organization. We will talk about how to motivate and incentivize your team and learn about the importance of understanding what drives your teams members and employees. Lastly, we will discuss Fereydoun’s exciting career trajectory in life science industry and venture capital to gain insight into real worlds scenarios that foster great leaders

Virtual

Please join a special Virtual Roundtable to hear about innovative approaches in health care leveraging technology and data to positively impact patient outcomes and experiences. This event will be moderated by Patricia Martone Carrolo, General Manager, IBM Global Healthcare and Life Sciences and the speakers are Angela Yochem, EVP, Chief Digital & Technology Officer, Novant Health and Neal Sample, EVP & Chief Information Officer, Northwestern Mutual> Please register by July 8th.

Webinar

HBS Executive Dean, Angela Crispi, will lead a discussion with Kate Walsh who is the CEO Boston Medical Center. As New England’s largest safety-net hospital, Kate will share how BMC is facing the leadership challenges and the stark reality of COVID and its impact on racial inequality, essential workers, and the care of the homeless. This hour-long discussion will also include a Q&A for participants to engage with Kate and Angela.

Virtual

Parth Chakrabarti, VP of Business Development at Vertex Pharmaceuticals, will be covering partnerships and alliances for life science startups. This will be an excellent opportunity to ask questions and openly discuss strategies for building R&D partnerships, alliances, licensing deals as a life science startup with large biopharma corporations. We will touch on how interact with potential partners, when to reach out, the different types of alliances, typical deal structures & terms, what to expect when negotiating and closing a deal, and developing an execution strategy.

Virtual

COVID-19 and world events have upended the world as we know it. The challenge for leaders is to provide direction in uncertain times and create culture that brings out the best in your team. Patricia Martone Carrolo (MBA 1991), General Manager, IBM Global Healthcare and Life Sciences, will lead a webinar with executive coaches Sharon Melnick, Ph.D. and John Baldoni will discuss how to demonstrate resilience in your leadership and team's performance, and demystify how coaching supports leaders' success. Please register by July 15th.

Virtual

David Resnick, patent attorney, partner, and biotechnology practice co-leader at Nixon Peabody, will be joining us to discuss intellectual property strategies for life science startups. We will talk about constructing a robust life science IP portfolio, as well as strategies used by startups to build a moat around your business & technology in order maximize your competitive advantage. Topics will include provisional vs non-provisional patents, PCT filings, deciding when to use patents vs trade secrets, establishing freedom to operate, managing IP, leveraging licensing opportunities, and strategies for filing patents.

Virtual

Join Peter Gladstone and Leo Guyshan and learn what elements help create a compelling and effective pitch deck. Learn the best ways to communicate your idea to investors, customers, and other key stakeholders.

Virtual

In March 2020, faulty CDC test kits and a surge of infections resulted in testing supply shortages across the nation. The recent involvement of the private sector has greatly expanded testing capabilities since, but pricing is still relatively high at roughly $100 per test. Annemarie Watson (MBA 2003) and Sean Murray (MBA 2010), are leading the effort at Eurofins Scientific to make “direct to business” testing both simple and cost effective. Join us to hear how Eurofins is simplifying the supply chain and combining innovative test technologies to potentially bring regular Covid-19 testing for <$10 per test to companies across the US before schools open in the fall. Please register by July 28th.

This program offers “due diligence” analysis on new & prospective companies’ technologies and business opportunities. In this program, graduate, medical, business, and law students; postdoctoral fellows; residents; and other members of the Harvard community will perform a deep dive into your company’s technology commercialization potential. The work product of this program is development of “Product Profile Sheets”, a business plan, and pitch decks tailored for presentation to specific audiences

Wasserstein Hall, Milstein East (2036) 1585 Massachusetts Ave. Cambridge, MA

Join us as we bring together federal-level government regulators of artificial intelligence technologies in North American, European, and Asian jurisdictions to highlight efforts around the globe to appropriately regulate the use of AI technologies in health care. The assembled regulators will discuss their initiatives in this area along with the challenges of regulating this unique and rapidly developing field.